IMM 1.45% 34.0¢ immutep limited

chinese competitor dendritic-cell therapy, page-49

  1. 338 Posts.
    lightbulb Created with Sketch. 15
    BRR

    In reference to your comment:

    "wonder if Martin's words will prove as hollow a second time around?"

    The latest run up in the SP was not actually on Martin's words, it was the announcement that PPR filed a registration statement for listing of ADR`s on NASDAQ.

    The market reacted to that news and built up it's own hype, he can't and shouldn't be held responsible for that

    Martin has also maintained that a listing date is out of his hands and has not set any expectation on when it will occur.
 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.